France: EssilorLuxottica to acquire Opetgra from MidEuropa
MidEuropa, a private equity investor historically focused on central and eastern Europe, has agreed to sell Optegra, an integrated ophthalmology platform operating in five key...
Switzerland: GlycoEra raises US$130m to advance novel pipeline of extracellular protein degraders for treatment...
GlycoEra, a Switzerland-based biotech company pioneering best-in-class extracellular protein degraders for the treatment of autoimmune diseases, has closed an oversubscribed US$130m Series B financing....
US: Valeris launches with integrated vision for Life Sciences companies
Mercalis, an integrated life sciences commercialization partner, has merged with PharmaCord, a provider of patient services for the biopharmaceutical industry, and rebranded as Valeris.
The...
France: Sanofi adding to neurology pipeline with acquisition of Vigil Neuroscience
Euronext and Nasdaq-listed global healthcare company, Sanofi, has entered into an agreement to acquire US-listed Vigil Neuroscience, a publicly traded clinical-stage biotechnology company focused...
Switzerland: Galderma repurchaes 2.38m shares from EQT, ADIA and Auba in context of ABO
SIX-listed Galderma, the pure-play dermatology company, has agreed to repurchase 2.38 million shares at a price of CHF97.75 per share for a total consideration of CHF232.5m (US$281.2m) in...
Malaysia: Diaverum acquires dialysis clinic in Kuala Lumpur
Diaverum, the Swedish-born global renal care provider, has acquired full ownership of IMU Dialysis in Kuala Lumpur, its first acquisition in Malaysia since entering...
Austria: Alantra acts as financial advisor to Perrigo on divestment of Richard Bittner
Alantra, a global alternative asset management, investment banking, and credit portfolio advisory firm, acted as exclusive financial advisor to Perrigo Company on the divestment...
Italy: CVC to sell Genetic stake to Renaissance
European investor CVC is selling its stake in Genetic, an Italy-based CDMO focused on the development and supply of products into the respiratory, ophthalmic...
France: Cinven to acquire Nutrisens from Sagard
UK-headquartered PE firm Cinven has revealed it is in exclusive negotiations with Canada-based Sagard MidCap to acquire France-based Nutrisens, alongside CEO & founder Georges...
US: SV Health Investors’ Dementia Discovery Fund Announces US$269m Final Close of DDF-2
The Dementia Discovery Fund (DDF), managed by SV Health Investors, has held the final close of its second fund, DDF-2, with US$269m in commitments....
Advertisement
